Large Cap Biopharmaceuticals Are in Buying Range with Good Value
Large Cap Biopharma stocks are in Buying Range Large cap biopharma stocks have attractive valuations and a growing pipeline of new products .The stocks are about 10% off prices from February, a seasonal peak. Among the strongest areas for product growth are oncology and autoimmune diseases so...
What’s the Next Sector Rotation trade after the S&P 500 Gained 1.8% last week and Chip stocks Soared? ….Update-3
Update-3..5/18-10:36a EDT...IBB and XBI down 1% but tape still looks good with several movers up:CRMD up 3%, NTRA up 4.37%,PSNL up 8.5%, VCYT up 5.5%. Large cap biotechs poised for gains: ABBV, BMY,MRK, NVS .Detailed report coming. Regeneron Is down over 10% on Ph.3 Melanoma drug disappoints ,...
SMID Cap Biopharma Trades for the next 4 Months…Update-2
Update-2...Digestion day after the huge run-up in AI semiconductor stocks yesterday. As one might expect few investors are paying attention to biotech stocks with the XBI down about 3% but holding a sight uptrend at $133. And the IWM is off its recent highs of $287 now in the $281 range....
Trending Towards Risk Off with Healthcare and Biotech Stocks…Update-3 Risk ON
Update-3... 5/1/26 ..After such big moves in the market this could be a good time to enjoy your profits and review your portfolio . Here are several SMID cap biotech stocks that we own, are in the money but poised for more gains: ABSI, ABOS, AXSM, COGT, ILMN, RCUS, XENE, XNCR. Small caps lagged...
What Is a Balanced Portfolio: Are You a Trader or an Investor?…Update-3
Update -3 Get ready for SMID cap biotech Q2/Q3 rally, historically strong because of ASCO. Here are several SMID stocks on our trading list that have made huge gains YTD with the XBI up 4.76%: APLs up 60%, CBIO up 55%, DNLI up 16%, DNTH up 103%, PTGX up 20%, SLDB up 27%, TWST up 49%, XENE up...